Because of the significant associations of S100A12 and LILRA5 with AS and IBD, the mRNA expression levels of the two genes in PBMCs extracted from 34 participants (12 healthy controls, 8 AS patients, 12 UC patients and 2 CD patients) were tested. Here, LILRA5 is linked to inflammatory bowel disease.